Effect of long-term cabergoline therapy on the immunological pattern and pituitary function of patients with idiopathic hyperprolactinaemia positive for antipituitary antibodies
- 15 July 2008
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 69 (2) , 285-291
- https://doi.org/10.1111/j.1365-2265.2008.03200.x
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Prolactin and AutoimmunityPituitary, 2005
- Prolactin and autoimmunityAutoimmunity Reviews, 2002
- Prolactin production by immune cellsLupus, 2001
- Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activityLupus, 2001
- Prolactin Secretion is Increased in Patients with Multiple SclerosisEndocrine Research, 1999
- Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout MiceEndocrine Reviews, 1998
- Action of Pituitary and Lymphocyte ProlactinNeuroimmunomodulation, 1997
- Review : Prolactin: a stimulator of disease activity in systemic lupus erythematosusLupus, 1995
- EXCESSIVE AND DYSREGULATED SECRETION OF PROLACTIN IN RHEUMATOID ARTHRITIS: IMMUNOPATHOGENETIC AND THERAPEUTIC IMPLICATIONSRheumatology, 1993
- A novel family of growth factor receptors: A common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor β-chainBiochemical and Biophysical Research Communications, 1989